Loading...
Assess the number of lung cancer detections after each round of screening.
Assess lung cancer mortality in participants included in the screening protocol and outside the protocol.
Asses all-cause mortality related to risk factors at the 3-years of LDCT screening and follow-up
Assess stage of the disease in patients detected by LDCT screening program
Assess Inflammatory cytokines
Assess nodule detection rate, characteristics and outcomes detected at the screening protocol.
Detect participants with a positive spirometry test that covers COPD diagnosis
Asses psychological diagnosis (anxiety/depression) related to a lung cancer screening program.